Profiles of People Who Carried Out Late Primary Vaccination against COVID-19 in the Region of Murcia

Author:

Bernal-Alonso Amaya1ORCID,Gómez-Moreno María Cruz2,Zornoza-Moreno Matilde2ORCID,Laorden-Ochando María Belén2,Tornel-Miñarro Francisca Isabel2,Pérez-Martín Jaime Jesús2ORCID

Affiliation:

1. Instituto de Salud Carlos III, 28029 Madrid, Spain

2. Prevention and Health Protection Service, Regional Ministry of Health, 30008 Murcia, Spain

Abstract

Despite the impact of the COVID-19 vaccination, vaccine hesitancy is a matter of concern. Despite a lower disease incidence, people continue to start primo-vaccination late. The aim of this study is to characterize people late primo-vaccinated and the reasons that led them to start vaccination. A quantitative, descriptive and prospective study was performed on the basis of phone surveys of people vaccinated from February to May 2022 in the Region of Murcia (Spain). The survey included socio-demographic and COVID-19 information, self-perception risk, vaccine security, Fear of COVID-19 Scale, reasons for not being vaccinated and reasons that have led them to vaccination. From a total of 1768 people receiving primo-vaccination, 798 people were contacted, and 338 people completed the survey. Among the interviewed people, 57% reported non-health-related reasons to get vaccinated, travel reasons being the primary one. The most reported health-related reason was a fear of COVID-19. There was a significant positive association between vaccination for health-related reasons and female gender (β = 0.72), cohabiting with a vulnerable person (β = 0.97), higher self-perceived risk (β = 0.13) and vaccine security dimension (β = 0.14). We identified two different profiles of people with late COVID-19 primo-vaccination, with health-related or non-health-related reasons. This work can be useful in designing specific communication strategies.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference33 articles.

1. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study;Watson;Lancet Infect. Dis.,2022

2. (2023, February 09). Consejos Para El Público Sobre La COVID-19: Vacunarse. Available online: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.

3. (2023, January 27). Profesionales-Estrategia de Vacunación COVID-19 en España. Available online: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/vacunaCovid19.htm.

4. (2023, January 27). Ley 41/2002, de 14 de Noviembre, Básica Reguladora de la Autonomía del Paciente y de Derechos y Obligaciones en Materia de Información y Documentación Clínica. Sect. 1, Ley 41/2002 Nov 15. 2002 . Available online: https://www.boe.es/eli/es/l/2002/11/14/41.

5. (2023, February 08). BOE-A-2011-15623 Ley 33/2011, de 4 de Octubre, General de Salud Pública. Available online: https://www.boe.es/buscar/act.php?id=BOE-A-2011-15623.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3